NSCLC is classified into several subtypes according to the driving genomic alterations, such as mutations in the BRAF, KRAS, HER2, and EGFR, as well as translocations of the gene encoding anaplastic lymphoma kinase (ALK), rearrangements of the gene encoding c-ros oncogene 1 receptor tyrosine kinase (ROS), and fusion of the gene encoding rearranged during transfection tyrosine kinase receptors (RET) [158]. Here, ALK is linked to non-small cell lung carcinoma.